-
SCHOTT reaches COVID-19 milestone: vials for one bn vaccine doses delivered
expresspharma
March 29, 2021
The success of the COVID-19 response is supported by the company’s multi-year, $1 billion global investment in pharmaceutical glass and packaging facilities announced early 2019.
-
We have supplied more vaccines globally than have vaccinated our own people: India to UN
expresspharma
March 29, 2021
India was one of the initiators of the 'Political Declaration on Equitable Global Access to COVID-19 Vaccines' that garnered the support of more than 180 UN member states.
-
SII postpones launch of Novavax vaccine in India
expresspharma
March 29, 2021
Poonawalla said earlier this month that a temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines such as Novavax.
-
India gives 1.2 million free doses of AstraZeneca COVID-19 vaccine to Bangladesh
expresspharma
March 29, 2021
Bangladesh has also signed a deal with the Serum Institute of India for 30 million doses of the AstraZeneca vaccine.
-
EMA Approves BioNTech's COVID Vax Production at Marburg Site
contractpharma
March 29, 2021
Largest mRNA vaccine manufacturing site in Europe has annual production capacity of up to one billion doses of its COVID-19 vaccine.
-
Will COVID-19 vaccines need to be adapted regularly?
worldpharmanews
March 26, 2021
Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines?
-
Could viral vector shortages disrupt the COVID-19 vaccine roll-out?
europeanpharmaceuticalreview
March 26, 2021
According to GlobalData, AstraZeneca’s and Janssen’s COVID-19 vaccines could be impacted by global viral vector shortages.
-
Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines
pharmaceutical-business-review
March 26, 2021
US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
-
Colombia approves J&J Covid-19 vaccine for emergency use
pharmaceutical-technology
March 26, 2021
The Colombian National Food and Drug Surveillance Institute (INVIMA) has approved Johnson & Johnson’s (J&J) single-shot Covid-19 vaccine for emergency use in the country.
-
AstraZeneca says COVID-19 vaccine 76 per cent effective in new analysis, to seek US approval
expresspharma
March 26, 2021
The European Union’s drug regulator said last week the vaccine was clearly safe, but Europeans remain skeptical about its safety.